ResearcherUniversity of Kansas Medical CenterNo recent work listed
Sharon Manley
Matched on ORCID iD 0000-0002-2411-9706; OpenAlex author ID A5025975925. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2021: 1 paper · 2022: 2 papers
Papers 3
- Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells. Co-author DOI 10.1038/s41419-022-04572-8↗
- Correction: Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells. Co-author DOI 10.1038/s41419-022-04615-0↗
- Suppression of pancreatic cancer liver metastasis by secretion-deficient ITIH5. First author DOI 10.1038/s41416-020-01093-z↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Appolinaire A. Olou · 2 shared papers, 2022 · strength 0.29
- Paper Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells. DOI 10.1038/s41419-022-04572-8↗
- Paper Correction: Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells. DOI 10.1038/s41419-022-04615-0↗
- Bailey A. Bye · 2 shared papers, 2022 · strength 0.29
- Paper Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells. DOI 10.1038/s41419-022-04572-8↗
- Paper Correction: Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells. DOI 10.1038/s41419-022-04615-0↗
- Mariana T. Ruckert · 2 shared papers, 2022 · strength 0.29
- Paper Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells. DOI 10.1038/s41419-022-04572-8↗
- Paper Correction: Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells. DOI 10.1038/s41419-022-04615-0↗
- Shrikant Anant · 2 shared papers, 2022 · strength 0.29
- Paper Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells. DOI 10.1038/s41419-022-04572-8↗
- Paper Correction: Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells. DOI 10.1038/s41419-022-04615-0↗
- Michael Nathan VanSaun · 2 shared papers, 2022 · strength 0.29
- Paper Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells. DOI 10.1038/s41419-022-04572-8↗
- Paper Correction: Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells. DOI 10.1038/s41419-022-04615-0↗
- R. McKinnon Walsh · 2 shared papers, 2022 · strength 0.29
- Paper Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells. DOI 10.1038/s41419-022-04572-8↗
- Paper Correction: Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells. DOI 10.1038/s41419-022-04615-0↗
- Eric D Young · 1 shared paper, 2021 · strength 0.11
- Danny R. Welch · 1 shared paper, 2021 · strength 0.11
- Ken Sasaki · 1 shared paper, 2021 · strength 0.11
- Michael Anthony Hollingsworth · 1 shared paper, 2021 · strength 0.11
- Paul M. Grandgenett · 1 shared paper, 2021 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.